What do we (need to) know about the kinetic properties of nanoparticles in the body?

Regulatory Toxicology and Pharmacology

Volumn 49, Issue 3, 2007, Pages 217-229

  Hagens, Werner I ^a   Oomen, Agnes G ^a   de Jong, Wim H ^a   Cassee, Flemming R ^a   Sips, Adriënne J A M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Absorption; ADME; Detection; Distribution; Excretion; Kinetics; Metabolism; Nanoparticles

Indexed keywords

NANOPARTICLE;

ABSORPTION; ARTICLE; EXCRETION; GEOMETRY; HEALTH HAZARD; HUMAN; NANOCHEMISTRY; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE DISTRIBUTION; TOXICOKINETICS;

ANIMALS; HUMANS; KINETICS; MODELS, BIOLOGICAL; NANOPARTICLES; PARTICLE SIZE; PHARMACOKINETICS;

EID: 36048947290     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.07.006     Document Type: Article

References (104)

1. Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotechnol. 1 (2004) 47-52
2. Andre E., Stoeger T., Takenaka S., Bahnweg M., Ritter B., Karg E., Lentner B., Reinhard C., Schulz H., and Wjst M. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur. Respir. J. 28 2 (2006) 275-285
3. Araujo L., Lobenberg R., and Kreuter J. Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug. Target. 5 (1999) 373-385
4. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., and Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 1 (2004) 79-86
5. Barrett E.G., Johnston C., Oberdorster G., and Finkelstein J.N. Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar type II cell line. Toxicol. Appl. Pharmacol. 2 (1999) 111-122
6. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., and Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 4 (1995) 493-498
7. Borm P.J., and Kreyling W. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J. Nanosci. Nanotechnol. 5 (2004) 521-531
8. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., and Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre. Toxicol. 3 (2006) 11
9. Bosman S.J., Nieto S.P., Patton W.C., Jacobson J.D., Corselli J.U., and Chan P.J. Development of mammalian embryos exposed to mixed-size nanoparticles. Clin. Exp. Obstet. Gynecol. 4 (2005) 222-224
10. Brown D.M., Wilson M.R., MacNee W., Stone V., and Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 3 (2001) 191-199
11. Brown J.S., Zeman K.L., and Bennett W.D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 9 (2002) 1240-1247
12. Cagle D.W., Kennel S.J., Mirzadeh S., Alford J.M., and Wilson L.J. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Natl. Acad. Sci. USA 96 9 (1999) 5182-5187
13. Carr K.E., Hazzard R.A., Reid S., and Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 8 (1996) 1205-1209
14. Coyle P., Philcox J.C., Carey L.C., and Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 4 (2002) 627-647
15. de Jong, W.H., Hagens, W.I., Krystek, P., de la Fonteyne, L.J.J., Verharen, H.W., Burger, M.C., Riool-Nesselaar, T., Sips, A.J.A.M., Geertsma, R.E., submitted for publication. Particle size dependent organ distribution of gold nanoparticles after intravenous administration: a quantitative and qualitative approach.
16. de Jong, W.H., Roszek, B., Geertsma, R.E., 2005. Nanotechnology in medical applications: possible risks for human health. RIVM report 265001002/2005.
17. de Zwart L.L., Haenen H.E., Versantvoort C.H., Wolterink G., van Engelen J.G., and Sips A.J. Role of biokinetics in risk assessment of drugs and chemicals in children. Regul. Toxicol. Pharmacol. 3 (2004) 282-309
18. des Rieux A., Fievez V., Garinot M., Schneider Y.J., and Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 1 (2006) 1-27
19. Desai M.P., Labhasetwar V., Amidon G.L., and Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 12 (1996) 1838-1845
20. Donaldson K., Stone V., Clouter A., Renwick L., and MacNee W. Ultrafine particles. Occup. Environ. Med. 58 3 (2001) 211-216 199
21. Elder A., Gelein R., Finkelstein J.N., Driscoll K.E., Harkema J., and Oberdorster G. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol. Sci. 2 (2005) 614-629
22. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., and Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 8 (2006) 1172-1178
23. Ferin J., Oberdorster G., and Penney D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 6 5 (1992) 535-542
24. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14 3 (1997) 259-266
25. Florence A.T. Nanoparticle uptake by the oral route: Fulfilling its potential?. Drug Discov. Today: Technol. 2 1 (2005) 75-81
26. Furumoto K., Ogawara K., Yoshida M., Takakura Y., Hashida M., Higaki K., and Kimura T. Biliary excretion of polystyrene microspheres depends on the type of receptor-mediated uptake in rat liver. Biochim. Biophys. Acta 1526 2 (2001) 221-226
27. Gamer A.O., Leibold E., and van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 20 3 (2006) 301-307
28. Gatti A.M. Biocompatibility of micro- and nano-particles in the colon. Part II. Biomaterials 25 3 (2004) 385-392
29. Gatti A.M., Montanari S., Monari E., Gambarelli A., Capitani F., and Parisini B. Detection of micro- and nano-sized biocompatible particles in the blood. J. Mater. Sci. Mater. Med. 15 4 (2004) 469-472
30. Gatti A.M., and Rivasi F. Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney. Biomaterials 23 11 (2002) 2381-2387
31. Geiser M., Cruz-Orive L.M., Im Hof V., and Gehr P. Assessment of particle retention and clearance in the intrapulmonary conducting airways of hamster lungs with the fractionator. J. Microsc. 160 Pt 1 (1990) 75-88
32. Geiser M., Rothen-Rutishauser B., Kapp N., Schurch S., Kreyling W., Schulz H., Semmler M., Im Hof V., Heyder J., and Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 113 11 (2005) 1555-1560
33. Gulson B., and Wong H. Stable isotopic tracing-a way forward for nanotechnology. Environ. Health Perspect. 114 10 (2006) 1486-1488
34. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 114 2 (2006) 165-172
35. Hillery A.M., Jani P.U., and Florence A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug. Target. 2 2 (1994) 151-156
36. Hillyer J.F., and Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 90 12 (2001) 1927-1936
37. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., Yasuhara M., Suzuki K., and Yamamoto K. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 4 11 (2004) 2163-2169
38. Howe H.A., and Bodian D. Portals of entry of poliomyelitis virus in the chimpanzee. Proc. Soc. Exp. Biol. Med. 43 (1940) 718-721
39. Hussain N., Jaitley V., and Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug. Deliv. Rev. 50 1-2 (2001) 107-142
40. ICRP (International Commission on Radiological Protection), 1994. Human respiratory tract model for radiological protection. ICRP Publication 66 Annals of ICRP, 24, 231.
41. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., and Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 73 2-3 (2001) 255-267
42. Jani P., Halbert G.W., Langridge J., and Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42 12 (1990) 821-826
43. x in mice. J. Nanoparticle Res. 8 (2006) 53-63
44. Kohli A.K., and Alpar H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int. J. Pharm. 275 1-2 (2004) 13-17
45. Kreyling W.G., Semmler-Behnke M., and Moller W. Ultrafine particle-lung interactions: does size matter?. J. Aerosol Med. 19 1 (2006) 74-83
46. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdorster G., and Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 65 20 (2002) 1513-1530
47. Kuempel E.D., Tran C.L., Castranova V., and Bailer A.J. Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal. Toxicol. 18 10 (2006) 717-724
48. Larson D.R., Zipfel W.R., Williams R.M., Clark S.W., Bruchez M.P., Wise F.W., and Webb W.W. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300 5624 (2003) 1434-1436
49. Lee H.J., Yeo S.Y., and Jeong S.H. Antibacterial effect of nanosized silver colloidal solution on textile fabrics. J. Mater. Sci. 38 (2003) 2199-2204
50. Lomer M.C., Thompson R.P., and Powell J.J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 61 1 (2002) 123-130
51. Lovric J., Bazzi H.S., Cuie Y., Fortin G.R., Winnik F.M., and Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 83 5 (2005) 377-385
52. Maynard A.D., and Kuempel E.D. Airborne nanostructured particles and occupational health. J. Nanoparticle Res. 7 (2005) 587-614
53. Maynard, A.D., Michelson, E. 2005. The nanotechnology consumer products inventory. Woodrow Wilson International Center for Scholars.
54. Mills N.L., Amin N., Robinson S.D., Anand A., Davies J., Patel D., de la Fuente J.M., Cassee F.R., Boon N.A., Macnee W., Millar A.M., Donaldson K., and Newby D.E. Do inhaled carbon nanoparticles translocate directly into the circulation in humans?. Am. J. Respir. Crit. Care Med. 173 4 (2006) 426-431
55. Moosmann B., and Behl C. Secretory peptide hormones are biochemical antioxidants: structure-activity relationship. Mol. Pharmacol. 61 2 (2002) 260-268
56. Nel A., Xia T., Madler L., and Li N. Toxic potential of materials at the nanolevel. Science 311 5761 (2006) 622-627
57. Nemmar A., Hoet P.H., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M.F., Vanbilloen H., Mortelmans L., and Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 105 4 (2002) 411-414
58. Nemmar A., Hoylaerts M.F., Hoet P.H., Vermylen J., and Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol. Appl. Pharmacol. 186 1 (2003) 38-45
59. Nemmar A., Vanbilloen H., Hoylaerts M.F., Hoet P.H., Verbruggen A., and Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care Med. 164 9 (2001) 1665-1668
60. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., Katayama Y., and Niidome Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release 114 3 (2006) 343-347
61. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health 74 1 (2001) 1-8
62. Oberdorster G., and Elder A. Metal particles and extrapulmonary transport: oberdorster and elder respond. Environ. Health. Perspect. 115 2 (2007) A70-A71
63. Oberdorster G., Ferin J., and Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102 Suppl 5 (1994) 173-179
64. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., and Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2 (2005) 8
65. Oberdorster G., Oberdorster E., and Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 7 (2005) 823-839
66. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., and Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16 6-7 (2004) 437-445
67. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., and Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A 65 20 (2002) 1531-1543
68. Ogawara K., Yoshida M., Furumoto K., Takakura Y., Hashida M., Higaki K., and Kimura T. Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats. J. Drug Target. 7 3 (1999) 213-221
69. Ogawara K., Yoshida M., Higaki K., Kimura T., Shiraishi K., Nishikawa M., Takakura Y., and Hashida M. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. J. Control. Release 59 1 (1999) 15-22
70. Olivier J.C. Drug transport to brain with targeted nanoparticles. NeuroRx 2 1 (2005) 108-119
71. Partidos C.D. Delivering vaccines into the skin without needles and syringes. Expert Rev. Vaccines 2 6 (2003) 753-761
72. Peters A., Veronesi B., Calderon-Garciduenas L., Gehr P., Chen L.C., Geiser M., Reed W., Rothen-Rutishauser B., Schurch S., and Schulz H. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol. 3 (2006) 13
73. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., and Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med. 15 4 (2004) 321-325
74. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., and Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90 2 (2006) 296-303
75. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug. Discov. 3 2 (2004) 115-124
76. Preining O. The physical nature of very, very small particles and its impact on their behaviour. J. Aerosol Sci. 5 6 (1998) 481-495
77. Price, O.T., Asgharian, B., Miller, F.J., Cassee, F.R., de Winter-Sorkina, R., 2002. Multiple Path Particle Dosimetry model (MPPD v1.0): a model for human and rat airway particle dosimetry. RIVM report 650010030.
78. Qingnuan L., yan X., Xiaodong Z., Ruili L., qieqie D., Xiaoguang S., Shaoliang C., and Wenxin L. Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies. Nucl. Med. Biol. 29 6 (2002) 707-710
79. Rajagopalan P., Wudl F., Schinazi R.F., and Boudinot F.D. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob. Agents Chemother. 40 10 (1996) 2262-2265
80. Revell P.A., al-Saffar N., and Kobayashi A. Biological reaction to debris in relation to joint prostheses. Proc. Inst Mech. Eng. [H] 211 2 (1997) 187-197
81. Roszek, B., de Jong, W.H., Geertsma, R.E., 2005. Nanotechnology in medical applications: state-of-the-art in materials and devices. RIVM report 265001001/2005.
82. Rothen-Rutishauser B.M., Schurch S., Haenni B., Kapp N., and Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol. 40 14 (2006) 4353-4359
83. Rouse J.G., Yang J., Ryman-Rasmussen J.P., Barron A.R., and Monteiro-Riviere N.A. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 7 1 (2007) 155-160
84. Ryman-Rasmussen J.P., Riviere J.E., and Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 91 1 (2006) 159-165
85. Sayes C.M., Fortner J.D., Guo W., Lyon D., Boyd A.M., Ausman K.D., Tao Y.J., Sitharaman B., Wilson L.J., Huges J.B., West J.L., and Colvin V.L. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4 10 (2004) 1881-1887
86. Schulz J., Hohenberg H., Pflucker F., Gartner E., Will T., Pfeiffer S., Wepf R., Wendel V., Gers-Barlag H., and Wittern K.P. Distribution of sunscreens on skin. Adv. Drug. Deliv. Rev. 54 Suppl 1 (2002) S157-S163
87. Scientific Committee on Emerging and Newly Identified Health Risk (SCENIHR), 2005. Opinion on: The appropriateness of existing methodologies to assess the potential risk associated with engineered and adventitious products of nanotechnologies. European Commision Health & Consumer Protection Directorate-General. Directorate C-Public Health and Risk Assesment C7-Risk Assessment. SCENIHR/002/05.
88. Semmler M., Seitz J., Erbe F., Mayer P., Heyder J., Oberdorster G., and Kreyling W.G. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal. Toxicol. 16 6-7 (2004) 453-459
89. Service R.F. Nanotechnology. Calls rise for more research on toxicology of nanomaterials. Science 310 5754 (2005) 1609
90. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., and Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA 103 9 (2006) 3357-3362
91. Tan M.H., Commens C.A., Burnett L., and Snitch P.J. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas. J. Dermatol. 37 4 (1996) 185-187
92. The Royal Society and The Royal Academy of Engineering, 2004. Nanoscience and nanotechnologies: opportunities and uncertainties, London, UK.
93. The Washington Post, 2006. EPA to regulate nanoproducts sold as germ-killing, 23 November 2006.
94. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., DePree K., and Adkins E.J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 111 9 (2003) 1202-1208
95. Tsuchiya T., Oguri I., Yamakoshi Y.N., and Miyata N. Novel harmful effects of [60] fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 393 1 (1996) 139-145
96. Tsuji J.S., Maynard A.D., Howard P.C., James J.T., Lam C.W., Warheit D.B., and Santamaria A.B. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol. Sci. 89 1 (2006) 42-50
97. Vermylen J., Nemmar A., Nemery B., and Hoylaerts M.F. Ambient air pollution and acute myocardial infarction. J. Thromb. Haemost. 3 9 (2005) 1955-1961
98. Veronesi B., de Haar C., Lee L., and Oortgiesen M. The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells. Toxicol. Appl. Pharmacol. 178 3 (2002) 144-154
99. Volkheimer G. Passage of particles through the wall of the gastrointestinal tract. Environ. Health Perspect. 9 (1974) 215-225
100. Volkheimer G., Schulz F.H., Aurich I., Strauch S., Beuthin K., and Wendlandt H. Persorption of particles. Digestion 1 2 (1968) 78-80
101. West D.P., Worobec S., and Solomon L.M. Pharmacology and toxicology of infant skin. J. Invest. Dermatol. 76 3 (1981) 147-150
102. Wiebert P., Sanchez-Crespo A., Seitz J., Falk R., Philipson K., Kreyling W.G., Moller W., Sommerer K., Larsson S., and Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur. Respir. J. 28 2 (2006) 286-290
103. Wittmaack K. search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what?. Environ. Health Perspect. 115 2 (2007) 187-194
104. Xia X.R., Monteiro-Riviere N.A., and Riviere J.E. Trace analysis of fullerenes in biological samples by simplified liquid-liquid extraction and high-performance liquid chromatography. J. Chromatogr. A 1129 2 (2006) 216-222